Analyze Diet
Vaccine2017; 35(33); 4140-4147; doi: 10.1016/j.vaccine.2017.06.052

Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.

Abstract: Borrelia burgdorferi can induce Lyme disease. Approved Lyme vaccines for horses are currently not available. In an effort to protect horses, veterinarians are using Lyme vaccines licensed for dogs. However, data to assess the response of horses to, or determine the efficacy of this off-label vaccine use are missing. Here, antibodies against outer surface protein A (OspA), OspC, and OspF were quantified in diagnostic serum submissions from horses with a history of vaccination with canine Lyme vaccines. The results suggested that many horses respond with low and often short-lasting antibody responses. Subsequently, four experimental vaccination trials were performed. First, we investigated antibody responses to three canine vaccines in B. burgdorferi-naïve horses. One killed bacterin vaccine induced antibodies against OspC. OspA antibodies were low for all three vaccines and lasted less than 16weeks. The second trial tested the impact of the vaccine dose using the OspA/OspC inducing bacterin vaccine in horses. A 2mL dose produced higher OspA and OspC antibody values than a 1mL dose. However, the antibody response again quickly declined, independent of dose. Third, the horses were vaccinated with 2 doses of a recombinant OspA vaccine. Previous vaccination and/or environmental exposure enhanced the magnitude and longevity of the OspA antibody response to about 20weeks. Last, the influence of intramuscular versus subcutaneous vaccine administration was investigated for the recombinant OspA vaccine. OspA antibody responses were not influenced by injection route. The current work highlights that commercial Lyme vaccines for dogs induce only transient antibody responses in horses which can also be of low magnitude. Protection from infection with B. burgdorferi should not be automatically assumed after vaccinating horses with Lyme vaccines for dogs.
Publication Date: 2017-06-28 PubMed ID: 28668566DOI: 10.1016/j.vaccine.2017.06.052Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses a study where horses are vaccinated with canine Lyme vaccines to protect against Lyme disease, but it produces only short-lived and often low antibody responses. Multiple trials were conducted to assess antibodies against specific Lyme bacteria proteins, test impact of vaccine dose, analyze the effect of double dosing, and compare different vaccine administration methods.

Experiment on Lyme Vaccines for Horses

  • The paper is centered around the lack of approved Lyme vaccines for horses leading veterinarians to use canine vaccines. Because there’s insufficient data on this off-label use, the researchers conducted several trials to understand its efficacy better.
  • The researchers analyzed the serum of horses with a history of vaccination with canine Lyme vaccines. They found low and often short-lasting antibody responses, suggesting the vaccines were not producing a strong or long-lasting immunity in horses.

Experimental Vaccine Trials

  • In the first trial, antibody responses to three canine vaccines were tested in Lyme bacteria-naïve horses. Only one vaccine induced antibodies against OspC, a protein associated with Lyme disease. However, the response to all three vaccines was low and lasted less than 16 weeks.
  • The second trial determined the impact of the vaccine dose using the OspA/OspC inducing bacterin vaccine in horses. A larger dose resulted in greater antibody values; however, the response quickly declined, regardless of dose size.
  • The third trial involved horses receiving two doses of a recombinant OspA vaccine. The researchers observed that environmental exposure or previous vaccination enhanced the response duration to 20 weeks, which was still not considerably long.
  • In the final trial, they compared the antibody responses prompted by intramuscular and subcutaneous administration of the recombinant OspA vaccine. They found that the method of administration did not influence the immune response significantly.

Conclusions of the Study

  • The research concluded that commercial Lyme vaccines intended for dogs only provoke temporary antibody responses in horses, which are often also of low magnitude.
  • It warns against the assumption that horses will automatically be protected from B. burgdorferi infection (Lyme disease) by vaccinating them with Lyme vaccines for dogs.

Cite This Article

APA
Guarino C, Asbie S, Rohde J, Glaser A, Wagner B. (2017). Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses. Vaccine, 35(33), 4140-4147. https://doi.org/10.1016/j.vaccine.2017.06.052

Publication

ISSN: 1873-2518
NlmUniqueID: 8406899
Country: Netherlands
Language: English
Volume: 35
Issue: 33
Pages: 4140-4147
PII: S0264-410X(17)30849-6

Researcher Affiliations

Guarino, Cassandra
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Asbie, Sanda
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Rohde, Jennifer
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Glaser, Amy
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Wagner, Bettina
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. Electronic address: bw73@cornell.edu.

MeSH Terms

  • Animals
  • Antibodies, Bacterial / blood
  • Antibody Formation
  • Antigens, Bacterial / immunology
  • Bacterial Outer Membrane Proteins / immunology
  • Borrelia burgdorferi / immunology
  • Dogs
  • Horse Diseases / prevention & control
  • Horses
  • Injections, Intramuscular
  • Lyme Disease / prevention & control
  • Lyme Disease / veterinary
  • Lyme Disease Vaccines / administration & dosage
  • Time Factors
  • Vaccination / methods
  • Veterinary Medicine / methods

Citations

This article has been cited 5 times.
  1. Guarino C, Pinn-Woodcock T, Levine DG, Miller J, Johnson AL. Case Report: Nuchal Bursitis Associated With Borrelia burgdorferi Infection in a Horse.. Front Vet Sci 2021;8:743067.
    doi: 10.3389/fvets.2021.743067pubmed: 34631864google scholar: lookup
  2. Hrnková J, Schneiderová I, Golovchenko M, Grubhoffer L, Rudenko N, Černý J. Role of Zoo-Housed Animals in the Ecology of Ticks and Tick-Borne Pathogens-A Review.. Pathogens 2021 Feb 16;10(2).
    doi: 10.3390/pathogens10020210pubmed: 33669161google scholar: lookup
  3. Goodrich EL, McLean A, Guarino C. A Pilot Serosurvey for Selected Pathogens in Feral Donkeys (Equus asinus).. Animals (Basel) 2020 Oct 2;10(10).
    doi: 10.3390/ani10101796pubmed: 33023217google scholar: lookup
  4. Černý J, Lynn G, Hrnková J, Golovchenko M, Rudenko N, Grubhoffer L. Management Options for Ixodes ricinus-Associated Pathogens: A Review of Prevention Strategies.. Int J Environ Res Public Health 2020 Mar 12;17(6).
    doi: 10.3390/ijerph17061830pubmed: 32178257google scholar: lookup
  5. Divers TJ, Gardner RB, Madigan JE, Witonsky SG, Bertone JJ, Swinebroad EL, Schutzer SE, Johnson AL. Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement.. J Vet Intern Med 2018 Mar;32(2):617-632.
    doi: 10.1111/jvim.15042pubmed: 29469222google scholar: lookup